Order Entry
United Kingdom
ContactUsLinkComponent
SR-4835 is a potent, highly selective and ATP competitive dual inhibitor of CDK12/CDK13 (CDK12: IC50=99 nM, Kd=98 nM CDK13: Kd=4.9 nM). SR-4835 acts in synergy with DNA-damaging chemotherapy and PARP inhibitors and provokes triple-negative breast ca 1 * 50 mg
Catalog # MDEXHY-130250
Supplier:  MEDCHEMEXPRESS
SR-4835 is a potent, highly selective and ATP competitive dual inhibitor of CDK12/CDK13 (CDK12: IC50=99 nM, Kd=98 nM CDK13: Kd=4.9 nM). SR-4835 acts in synergy with DNA-damaging chemotherapy and PARP inhibitors and provokes triple-negative breast ca 1 * 50 mg
Catalog # MDEXHY-130250
Supplier:  MEDCHEMEXPRESS
Frequently Bought Together